iRhythm Technologies, Inc., commonly known as iRhythm, is a pioneering company headquartered in the United States, with significant operations across North America and Europe. Founded in 2006, iRhythm has established itself in the healthcare technology industry, focusing on innovative solutions for cardiac monitoring. The company is renowned for its flagship product, Zio, a wearable ECG monitoring device that offers continuous heart rhythm analysis. This unique approach allows for more accurate diagnoses and improved patient outcomes, setting iRhythm apart in a competitive market. With a commitment to advancing cardiac care, iRhythm has achieved notable milestones, including FDA approvals and partnerships with leading healthcare providers. Its position as a leader in digital health solutions underscores its dedication to transforming the way cardiac conditions are monitored and managed.
How does Irhythm's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Irhythm's score of 38 is higher than 63% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, iRhythm Technologies, Inc., headquartered in the US, reported total carbon emissions of approximately 502,219 kg CO2e. This figure includes 4,345 kg CO2e from Scope 2 emissions (market-based) and 497,874 kg CO2e from Scope 3 emissions. Notably, the company maintained zero emissions in Scope 1. Comparatively, in 2022, iRhythm's emissions were significantly higher, with Scope 1 emissions at 67,070 kg CO2e and Scope 2 emissions (location-based) at 541,030 kg CO2e, resulting in a total of about 608,100 kg CO2e for Scope 1 and 2 combined. iRhythm has set ambitious climate commitments, aiming to maintain Scope 1 emissions at zero through 2030. Additionally, the company plans to reduce its market-based Scope 2 emissions to zero by 2025 and sustain this reduction beyond that year. These targets reflect a strong commitment to achieving net-zero emissions in the near term, aligning with industry standards for climate action. The emissions data is not cascaded from any parent organization, indicating that iRhythm is independently reporting its carbon footprint and climate initiatives.
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 67,070 | - |
| Scope 2 | 541,030 | 0,000 |
| Scope 3 | - | 000,000 |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Irhythm has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

